BD (Becton, Dickinson and Company) Biosciences manufactures anticytokeratin CAM5.2, not CK8/18 monoclonal antibody.

摘要

In the recent report entitled 'Malignant adenomyoepithelioma of the breast combined with invasive lobular carcinoma', the authors summarized the antigens detected, as well as incorporated all the sources of antibodies used, their dilutions and staining results of immunohistochemistry in a table. However, they might have inadvertently annotated that Becton Dickinson and Company (BD) (San Jose, CA, USA) produces antibody to react with CK8/18 antigen.